Biotimize
Contract Development & Manufacturing Organization
Global Vision & End-to-End Bioprocess Execution
Biotimize operates with a long-term global vision and a Phase-Appropriate regulatory architecture embedded from day zero. We empower biotechs and global biopharma leaders with custom bioprocess design, structured technology transfer, and scalable manufacturing pathways supporting a predictable transition fro discovery to clinical readiness.
Complete Life-Cycle Support: Transfer or Scale with Us
We design bioprocesses that are built to travel or built to grow. Whether your strategic roadmap calls for technology transfer to an international partner or long-term manufacturing within our expanding facility, Biotimize provides end-to-end operational continuity.
Should your commercial strategy require manufacturing at a global CMO partner, we deliver a fully documented, phase-appropriate Tech Transfer package (ICH Q8-Q11 compliant) ensuring smooth, frictionless onboarding at target sites worldwide.
Grow your pipeline directly with Biotimize. Our modular facility design allows seamless capacity scaling alongside your clinical trajectory—providing reliable, ongoing supply from early-stage trials through initial commercial launch.
Building the Future of Flexible Biomanufacturing
Fully single-use infrastructure ensuring maximum operational flexibility, rapid product changeover, and minimum risk of cross-contamination.
Initial operational bioreactor capacities up to 200L—ideal for high-value therapeutics, advanced therapies, recombinant proteins, and clinical supply.
Seamless scale-up execution transferring benchtop processes into robust pilot and clinical-scale bioreactors with validated comparability metrics.
Designed for Stringent Global Compliance
Our facility layout, cleanroom architecture, and quality management systems are engineered from the ground up to comply with the world's most rigorous regulatory authorities:
Strict adherence to ICH Guidelines (Q8 Pharmaceutical Development, Q9 Quality Risk Management, Q10 Pharmaceutical Quality System, and Q11 Development & Manufacture) to support robust regulatory documentation across international markets.
Secure Priority Capacity
Partner with Biotimize early to lock in custom bioprocess design, early tech transfer slots, and Capacity Reservation for upcoming clinical and pilot supply runs.
Reserve CapacityJoin Our Growth Journey
We are currently raising capital to accelerate facility development and expand Biotimize's CDMO manufacturing capabilities.
Access Investor DeckLet’s Build the Next Generation of Biomanufacturing Together
Whether you are looking for a trusted CDMO partner for end-to-end tech transfer or seeking to participate in our capital raise, our executive team is ready to connect.
Schedule Executive Consultation